1. Home
  2. MBIO
  3. MBIO News

Latest Mustang Bio Inc. (MBIO) News on April 28, 2025

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement
MBIO

GlobeNewswire

2 months ago

Mustang Bio Regains Compliance with Nasdaq Capital Market Requirement

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility
MBIO

GlobeNewswire

2 months ago

Mustang Bio Announces Sale of Fixed Assets and Exit of Facility

Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement
MBIO

GlobeNewswire

3 months ago

Mustang Bio Regains Compliance with Nasdaq Minimum Bid Price Requirement

Mustang Bio Announces Closing of $8 Million Public Offering
MBIO

GlobeNewswire

3 months ago

Mustang Bio Announces Closing of $8 Million Public Offering

Mustang Bio Announces Pricing of $8 Million Public Offering
MBIO

GlobeNewswire

3 months ago

Mustang Bio Announces Pricing of $8 Million Public Offering

Mustang Bio Announces Reverse Stock Split
MBIO

GlobeNewswire

3 months ago

Mustang Bio Announces Reverse Stock Split

Mustang Bio Receives Positive Listing Determination from Nasdaq
MBIO

GlobeNewswire

6 months ago

Mustang Bio Receives Positive Listing Determination from Nasdaq

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment
MBIO

Pharmaceutical Technology

6 months ago

Mustang Bio’s MB-108 receives FDA orphan drug status for glioma treatment

MBIO

MT Newswires

6 months ago

Mustang Bio Gets FDA Orphan Drug Designation for MB-108 in Malignant Glioma Treatment

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma
MBIO

GlobeNewswire

6 months ago

Mustang Bio Granted Orphan Drug Designation by U.S. FDA for MB-108 (HSV-1 oncolytic virus) to Treat Malignant Glioma

Mustang Bio Secures $4M through Strategic Warrant Agreement
MBIO

TipRanks

6 months ago

Mustang Bio Secures $4M through Strategic Warrant Agreement

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds
MBIO

GlobeNewswire

6 months ago

Mustang Bio Announces Exercise of Warrants for $4 Million Gross Proceeds

MBIO

GlobeNewswire

10 months ago

Diamond Equity Research Releases Update Note on Enveric Biosciences Inc. (NASDAQ: ENVB)

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
MBIO

GlobeNewswire

10 months ago

Mustang Bio Announces Closing of $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

MBIO

MT Newswires

10 months ago

Mustang Bio to Raise $2.5 Million From Share Offering

MBIO

MT Newswires

10 months ago

Mustang Bio Expects $2.5 Million Gross Proceeds From Registered Direct Offering, Private Placement

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
MBIO

GlobeNewswire

10 months ago

Mustang Bio Announces $2.5 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study
MBIO

Zacks

10 months ago

Mustang (MBIO) Soars 477% on Data From Rare Blood Cancer Study

Citi raises its S&P 500 target, Boeing CEO testifies: Yahoo Finance
MBIO

Yahoo Finance Video

10 months ago

Citi raises its S&P 500 target, Boeing CEO testifies: Yahoo Finance

MBIO

MT Newswires

10 months ago

Top Midday Gainers

MBIO

MT Newswires

10 months ago

Sector Update: Health Care Stocks Ease in Afternoon Trading

MBIO

MT Newswires

10 months ago

Mustang Bio Shares Rise After Company Says CAR-T Therapy Indicates 90% Response Rate in WM Blood Cancer Trial

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy
MBIO

GlobeNewswire

10 months ago

Mustang Bio Announces Favorable Efficacy and Safety Data from Complete Waldenstrom Macroglobulinemia Cohort of Phase 1/2 Clinical Trial of MB-106, CD20-Targeted Autologous CAR-T Therapy

FDA panel votes to recommend Eli Lilly's Alzheimer's drug
MBIO

Yahoo Finance Video

a year ago

FDA panel votes to recommend Eli Lilly's Alzheimer's drug

MBIO

GlobeNewswire

a year ago

Chu Vision Institute Unveils Comprehensive Guide to LASIK Recovery and Aftercare, Pioneering Patient Care in Minneapolis

California seeks company profits in Big Oil climate lawsuit
MBIO

Reuters

a year ago

California seeks company profits in Big Oil climate lawsuit

MBIO

USA TODAY

a year ago

S&P 500, Nasdaq post record closing highs; Fed meeting, CPI ahead

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis
MBIO

GlobeNewswire

a year ago

Ipsen’s Iqirvo® receives U.S. FDA accelerated approval as a first-in-class PPAR treatment for primary biliary cholangitis

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock
MBIO

Business Wire

a year ago

Dutch Bros Inc. Announces Launch of Secondary Public Offering of Class A Common Stock

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas
MBIO

Business Wire

a year ago

Media Advisory: Federal Housing Finance Agency Director Sandra Thompson Visits Affordable Apartment Complex in Dallas

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research
MBIO

GlobeNewswire

a year ago

Global Polycaprolactone Market to Record Revenue Worth US$ 1535.5 Mn by 2034; Anticipated to Experience CAGR of 10.3% During 2024 – 2034; states TNR, The Niche Research

Mustang Bio Announces Closing of $4 Million Public Offering
MBIO

GlobeNewswire

a year ago

Mustang Bio Announces Closing of $4 Million Public Offering

MBIO

MT Newswires

a year ago

Mustang Bio Prices Public Offering of 16.9 Million Shares, Accompanying Warrants

Mustang Bio Announces Pricing of $4 Million Public Offering
MBIO

GlobeNewswire

a year ago

Mustang Bio Announces Pricing of $4 Million Public Offering

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases
MBIO

GlobeNewswire

a year ago

Mustang Bio Announces Vision for CAR T-Cell Therapy Platform Expansion into Autoimmune Diseases

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights
MBIO

GlobeNewswire

a year ago

Mustang Bio Reports Full-Year 2023 Financial Results and Recent Corporate Highlights

Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma
MBIO

GlobeNewswire

a year ago

Mustang Bio Announces Publication in Nature Medicine of Data from Phase 1 Trial Evaluating MB-101 IL13Rα2-targeted CAR T-Cells in High-Grade Glioma

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain
MBIO

GlobeNewswire

a year ago

InterCure Signs Definitive Agreement to Acquire Leon Cannabis Pharmacy Chain

Xos, Inc. Ranked Number 51 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™
MBIO

GlobeNewswire

a year ago

Xos, Inc. Ranked Number 51 Fastest-Growing Company in North America on the 2023 Deloitte Technology Fast 500™

Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.
MBIO

GlobeNewswire

a year ago

Biora Therapeutics Announces Participation in Fireside Chat Hosted by H.C. Wainwright & Co.

Movano Health Announces Evie Rings Now Shipping
MBIO

PR Newswire

a year ago

Movano Health Announces Evie Rings Now Shipping

RYVYL to Present at Sequire Investor Summit 2024 in Puerto Rico
MBIO

GlobeNewswire

a year ago

RYVYL to Present at Sequire Investor Summit 2024 in Puerto Rico

Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis
MBIO

GlobeNewswire

a year ago

Enlivex Receives IMOH Regulatory Authorization for the Initiation of a Multi-Country, Randomized, Controlled Phase I/II Trial Evaluating Allocetra in Up To 160 Patients with Moderate to Severe Knee Osteoarthritis

How Beamr Technology Can Boost Machine Learning
MBIO

ACCESSWIRE

a year ago

How Beamr Technology Can Boost Machine Learning

3 Natural Food Stocks in Focus on Impressive Industry Trends
MBIO

Zacks

a year ago

3 Natural Food Stocks in Focus on Impressive Industry Trends

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference
MBIO

GlobeNewswire

a year ago

Mustang Bio to Participate in the B. Riley Securities 4th Annual Oncology Conference

Zacks Industry Outlook Highlights Qorvo and RF Industries
MBIO

Zacks

a year ago

Zacks Industry Outlook Highlights Qorvo and RF Industries

Sadot Group Inc. Announces New Trading Arm - Sadot Brasil Ltda
MBIO

ACCESSWIRE

a year ago

Sadot Group Inc. Announces New Trading Arm - Sadot Brasil Ltda

Carbon Revolution plc Wheel Production More Than Tripled in Q4 CY2023 from Previous Year Quarter
MBIO

GlobeNewswire

a year ago

Carbon Revolution plc Wheel Production More Than Tripled in Q4 CY2023 from Previous Year Quarter

Upexi CEO, Allan Marshall, to Present at the iAccess Alpha 2024 Buyside Best Ideas Summit on January 9th & 10th
MBIO

ACCESSWIRE

a year ago

Upexi CEO, Allan Marshall, to Present at the iAccess Alpha 2024 Buyside Best Ideas Summit on January 9th & 10th

Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule
MBIO

GlobeNewswire

a year ago

Entera Bio Receives Extension from Nasdaq to Regain Compliance with Minimum Bid Price Rule

Harrow Partners with Leading Healthcare Market Access Technology Platforms
MBIO

Business Wire

a year ago

Harrow Partners with Leading Healthcare Market Access Technology Platforms

Electra Appoints 30-year Finance Veteran as CFO and Provides Financing Update
MBIO

Business Wire

a year ago

Electra Appoints 30-year Finance Veteran as CFO and Provides Financing Update

Clene Announces New Data from HEALEY ALS Platform Trial
MBIO

NewMediaWire

a year ago

Clene Announces New Data from HEALEY ALS Platform Trial

Akili, Inc. (AKLI) Upgraded to Buy: Here's What You Should Know
MBIO

Zacks

a year ago

Akili, Inc. (AKLI) Upgraded to Buy: Here's What You Should Know

Clene Provides Update on ALS Clinical Development Meeting With FDA
MBIO

GlobeNewswire

a year ago

Clene Provides Update on ALS Clinical Development Meeting With FDA

Integra Submits Draft Mine Plan of Operations for the DeLamar Project
MBIO

GlobeNewswire

a year ago

Integra Submits Draft Mine Plan of Operations for the DeLamar Project

ECD’s LS3-Powered Series 3 E-Type Brings Iconic British Heritage to America
MBIO

GlobeNewswire

a year ago

ECD’s LS3-Powered Series 3 E-Type Brings Iconic British Heritage to America

Alliance Entertainment’s AMPED Distribution Helps Power New Album Launch of K-Pop Band ATEEZ
MBIO

GlobeNewswire

a year ago

Alliance Entertainment’s AMPED Distribution Helps Power New Album Launch of K-Pop Band ATEEZ

Quantum-Si Expands Global Reach with Addition of New Distributor
MBIO

Business Wire

a year ago

Quantum-Si Expands Global Reach with Addition of New Distributor

Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer
MBIO

GlobeNewswire

a year ago

Candel Therapeutics Receives FDA Fast Track Designation for CAN-2409 in Pancreatic Cancer

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting
MBIO

GlobeNewswire

a year ago

Mustang Bio Presents Updated Phase 1/2 Multicenter Clinical Data for MB-106 at the 2023 American Society of Hematology (ASH) Annual Meeting

Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)
MBIO

GlobeNewswire

a year ago

Affimed Announces Updated Phase 1/2 Data from Acimtamig in Combination with Allogeneic NK in Hodgkin Lymphoma Patients Who Failed Prior Chemotherapy and Are Double-Refractory to Brentuximab Vedotin (BV) and Checkpoint Inhibitors (CPIs)

Sphere 3D Corp. Provides November 2023 Production and Operation Updates
MBIO

Newsfile

a year ago

Sphere 3D Corp. Provides November 2023 Production and Operation Updates

GreenPower Announces First Order of Nano BEAST All-Electric School Buses for the New York Market
MBIO

CNW Group

a year ago

GreenPower Announces First Order of Nano BEAST All-Electric School Buses for the New York Market

Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24
MBIO

GlobeNewswire

a year ago

Affimed to Host Investor Conference Call Highlighting Clinical Data for Acimtamig (AFM13) and AFM24

Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth
MBIO

InvestorPlace

a year ago

Penny Stock Powerhouses: 7 Picks Poised for Explosive Growth

MBIO

Associated Press Finance

a year ago

Bright Scholar: Fiscal Q4 Earnings Snapshot

MBIO

PR Newswire

a year ago

Bright Scholar Announces Unaudited Financial Results for the Fourth Fiscal Quarter and Fiscal Year 2023

The past five years for MediciNova (NASDAQ:MNOV) investors has not been profitable
MBIO

Simply Wall St.

a year ago

The past five years for MediciNova (NASDAQ:MNOV) investors has not been profitable

Singular Genomics Systems Founder Acquires 4.6% More Stock
MBIO

Simply Wall St.

a year ago

Singular Genomics Systems Founder Acquires 4.6% More Stock

Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa
MBIO

GlobeNewswire

a year ago

Dyadic’s C1 Platform to be Used to Produce Vaccines for Humans and Animals in Africa

The Consensus EPS Estimates For Broadwind, Inc. (NASDAQ:BWEN) Just Fell A Lot
MBIO

Simply Wall St.

a year ago

The Consensus EPS Estimates For Broadwind, Inc. (NASDAQ:BWEN) Just Fell A Lot

P3 Health Partners to Present at the BTIG Digital Health Forum
MBIO

Business Wire

a year ago

P3 Health Partners to Present at the BTIG Digital Health Forum

AGM Group Holdings Full Year 2022 Earnings: EPS: US$0.47 (vs US$0.17 in FY 2021)
MBIO

Simply Wall St.

a year ago

AGM Group Holdings Full Year 2022 Earnings: EPS: US$0.47 (vs US$0.17 in FY 2021)

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript
MBIO

Insider Monkey

a year ago

Singular Genomics Systems, Inc. (NASDAQ:OMIC) Q3 2023 Earnings Call Transcript

Pioneer's Third Quarter Revenue Increases 99.1% to a Record $12.4 Million; Grows Profitability to $0.10 in Quarterly EPS
MBIO

PR Newswire

a year ago

Pioneer's Third Quarter Revenue Increases 99.1% to a Record $12.4 Million; Grows Profitability to $0.10 in Quarterly EPS

Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights
MBIO

GlobeNewswire

a year ago

Mustang Bio Reports Third Quarter 2023 Financial Results and Recent Corporate Highlights

Verde Clean Fuels, Inc. Reports Third Quarter 2023 Earnings
MBIO

Business Wire

a year ago

Verde Clean Fuels, Inc. Reports Third Quarter 2023 Earnings

Time To Worry? Analysts Are Downgrading Their Brilliant Earth Group, Inc. (NASDAQ:BRLT) Outlook
MBIO

Simply Wall St.

a year ago

Time To Worry? Analysts Are Downgrading Their Brilliant Earth Group, Inc. (NASDAQ:BRLT) Outlook

Inuvo Reports Record Quarterly Revenue of $24.6 Million, a 44% Year-Over-Year Increase for the Third Quarter of 2023
MBIO

GlobeNewswire

a year ago

Inuvo Reports Record Quarterly Revenue of $24.6 Million, a 44% Year-Over-Year Increase for the Third Quarter of 2023

MBIO

Associated Press Finance

a year ago

Regulus: Q3 Earnings Snapshot

Regulus Therapeutics Reports Third Quarter 2023 Financial Results and Recent Updates
MBIO

PR Newswire

a year ago

Regulus Therapeutics Reports Third Quarter 2023 Financial Results and Recent Updates

Inuvo Enhances its AI-Generated IntentKey Insights Dashboard for Clients
MBIO

GlobeNewswire

a year ago

Inuvo Enhances its AI-Generated IntentKey Insights Dashboard for Clients

BEST Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee
MBIO

PR Newswire

a year ago

BEST Inc. Announces Receipt of a Preliminary Non-Binding Proposal to Acquire the Company and Formation of Special Committee

BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®
MBIO

GlobeNewswire

a year ago

BioCryst and Clearside Biomedical Enter Partnership to Develop Avoralstat for Diabetic Macular Edema Using Clearside’s Proprietary SCS Microinjector®

MiNK Therapeutics Insider Ups Holding During Year
MBIO

Simply Wall St.

a year ago

MiNK Therapeutics Insider Ups Holding During Year

Regulus Therapeutics Announces First Patient Dosed in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)
MBIO

PR Newswire

a year ago

Regulus Therapeutics Announces First Patient Dosed in Third Cohort of Phase 1b Multiple-Ascending Dose (MAD) Clinical Trial of RGLS8429 for the Treatment of Autosomal Dominant Polycystic Kidney Disease (ADPKD)

Share on Social Networks: